Pacific Center for Financial Services’s Novo Nordisk NVO Stock Holding History

Pacific Center for Financial Services’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.9K	Hold	270	–	–	﹤0.01%	319
2026 Q1	$9.92K	Hold	270	–	–	﹤0.01%	329
2025 Q4	$15K	Hold	270	–	–	﹤0.01%	292
2025 Q3	$15K	Hold	270	–	–	﹤0.01%	292
2025 Q2	$18.6K	Hold	270	–	–	0.01%	261
2025 Q1	$18.7K	Hold	270	–	–	0.01%	259
2024 Q4	$23.2K	Hold	270	–	–	0.01%	247
2024 Q3	$32.1K	Hold	270	–	–	0.01%	213
2024 Q2	$38.5K	Hold	270	–	–	0.01%	194
2024 Q1	$34.7K	Hold	270	–	–	0.01%	207
2023 Q4	$27.9K	Hold	270	–	–	0.01%	205
2023 Q3	$24.6K	Hold	270	–	–	0.01%	216
2023 Q2	$21.8K	Hold	270	–	–	0.01%	224
2023 Q1	$21.5K	Buy	+270	New	+$19.1K	0.01%	220
2022 Q3	$13K	Hold	270	–	–	0.01%	264
2022 Q2	$15K	Hold	270	–	–	0.01%	250
2022 Q1	$15K	Hold	270	–	–	0.01%	252
2021 Q4	$15K	Buy	270 +70	+35%	+$3.79K	0.01%	256
2021 Q3	$10K	Hold	200	–	–	﹤0.01%	284
2021 Q2	$8K	Hold	200	–	–	﹤0.01%	276
2021 Q1	$7K	Buy	+200	New	+$7.12K	﹤0.01%	269

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Pacific Center for Financial Services's NVO Position: Q2 2026 in Review

Pacific Center for Financial Services held its Novo Nordisk (NVO) position steady in Q2 2026 at 270 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #319.

Pacific Center for Financial Services first reported a position in NVO in Q1 2021 and has held it in 21 quarters since. The position peaked at $38.5K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Pacific Center for Financial Services held 270 shares of Novo Nordisk worth $12.9K as of Q2 2026.
Pacific Center for Financial Services left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up ﹤0.01% of Pacific Center for Financial Services's portfolio in Q2 2026, its #319 holding.
Pacific Center for Financial Services first reported a position in Novo Nordisk in Q1 2021 and has held it in 21 quarters since.
Pacific Center for Financial Services's Novo Nordisk position peaked at $38.5K in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Pacific Center for Financial Services's 13F filing for Q2 2026, filed 5 Aug 2026.